R-MG group had significantly shorter drug reducing duration than NR-MG, and there were numerical trends of less duration from steroid initiation to stable status, lower accumulated steroid doses before stable status and higher steroid-reducing speed in R-MG group, which were approaching significance, whereas no statistical difference was found in clinical characteristics.
← all excerpts
Clinical Predictors of Relapse in a Cohort of Steroid-Treated Patients With Well-Controlled Myasthenia Gravis.
1
—
—